Magnitude of Drug–Drug Interactions in Special Populations

Drug–drug interactions (DDIs) are one of the most frequent causes of adverse drug reactions or loss of treatment efficacy. The risk of DDIs increases with polypharmacy and is therefore of particular concern in individuals likely to present comorbidities (i.e., elderly or obese individuals). These sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bettonte, Sara, Berton, Mattia, Marzolini, Catia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027396/
https://www.ncbi.nlm.nih.gov/pubmed/35456623
http://dx.doi.org/10.3390/pharmaceutics14040789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027396/
https://www.ncbi.nlm.nih.gov/pubmed/35456623
http://dx.doi.org/10.3390/pharmaceutics14040789

Ejemplares similares